MIAMI, Sept. 30, 2025 (GLOBE NEWSWIRE) — Vivex Biologics, a leader in developing and delivering innovative allografts, today announced that it has treated the first patient in its Restore U.S.

1 Department of Neurosurgery, The Third Hospital of Shijiazhuang, Shijiazhuang, China 2 Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China Objectives: To ...

Abstract: X-ray image based medical report generation achieves significant progress in recent years with the help of large language models, however, these models have not fully exploited the effective ...

Insurance denied 18-year-old Nala White’s surgery for degenerative disc disease. After NBC News reached out, it was approved the next day. By the time she graduated high school, the back pain that ...

Single-level cervical degenerative disc disease saw better outcomes when addressed with disc replacement instead of anterior cervical discectomy and fusion, according to a meta-analysis of randomized ...

Findings from an interim analysis showed CELZ-201-DDT statistically significantly reduced pain and improved mobility in patients with chronic lower back pain. The Food and Drug Administration (FDA) ...

Although 67% of participants treated with SB-01 achieved the primary endpoint at 6 months, the difference when compared with sham treatment was not statistically significant. Topeline data were ...

Spine BioPharma Announces Topline Results from Phase 3 MODEL Trial For SB-01 (vicatertide) In Chronic Low Back Pain Associated with Degenerative Disc Disease Spine BioPharma, Inc. announced today the ...

Abstract: Medical imaging plays a pivotal role in disease diagnosis and prediction, where X-ray imaging stands out as a widely employed modality due to its accessibility and efficacy. However, the ...